However, treating DD-FBs with plasmin led to a significantly decreased expression of α-SMA, LAP-TGF-β, and PAI, therefore alleviating the symptoms of DD (Figure 8A–C). This evidence concerns the gene TGFB1 and dentin dysplasia.